Turnaround times for ethics review have returned to pre-COVID levels.
Unless requested to do so, the research ethics boards (REBs) are no longer prioritizing COVID-19 related research. Please contact the REB you are submitting to if you have specific questions.
Researchers with drugs, treatments or medical devices that may be effective in treating or diagnosing COVID-19 are encouraged to contact the Public Health Agency of Canada for assistance with facilitating clinical trials.
Please see Health Canada’s Notice to clinical trial sponsors on the management of clinical trials during the COVID-19 pandemic. Please contact your institutional clinical trials operations or your research ethics board for more information.
Clinical researchers should also be aware of the US FDA Guidance on Conduct of Clinical Trials of Medical products during the COVID-19 pandemic.